Bruker (BRKR) Operating Leases (2019 - 2025)
Bruker (BRKR) posted Operating Leases of $138.6 million for Q4 2025, up 16.57% on a QoQ basis from $118.9 million in Q4 2024, and up 16.57% year-over-year from $118.9 million in Q4 2024.
Bruker (BRKR) Operating Leases (2019 - 2025) Analysis & Trends
Bruker's Operating Leases history runs 7 years deep, the most recent figure standing at $138.6 million for Q4 2025.
- Quarterly Operating Leases rose 16.57% year-over-year to $138.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $138.6 million (up 16.57% YoY) and the FY2025 annual result came in at $138.6 million, up 16.57% from the prior year.
- Operating Leases was $138.6 million for Q4 2025 at Bruker, up from $118.9 million in the prior quarter.
- Across five years, Operating Leases topped out at $138.6 million in Q4 2025 and bottomed at $34.8 million in Q4 2022.
- A 5-year average of $90.8 million and a median of $98.5 million in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2022 — Operating Leases fell 16.75% — and 2023, when it soared 114.94%.
- Bruker's Operating Leases stood at $41.8 million in 2021, then decreased by 16.75% to $34.8 million in 2022, then surged by 114.94% to $74.8 million in 2023, then jumped by 58.96% to $118.9 million in 2024, then increased by 16.57% to $138.6 million in 2025.
- Business Quant data shows BRKR's Operating Leases at $138.6 million in Q4 2025, $118.9 million in Q4 2024, and $120.5 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Bruker | 9.46 Bn | 9.50 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 138.60 Mn |
| Dec 31, 2024 | 118.90 Mn |
| Sep 30, 2024 | 120.50 Mn |
| Jun 30, 2024 | 111.30 Mn |
| Mar 31, 2024 | 85.70 Mn |
| Dec 31, 2023 | 74.80 Mn |
| Dec 31, 2022 | 34.80 Mn |
| Dec 31, 2021 | 41.80 Mn |
| Dec 31, 2020 | 47.00 Mn |
| Sep 30, 2020 | 42.10 Mn |
| Jun 30, 2020 | 42.40 Mn |
| Mar 31, 2020 | 44.30 Mn |
| Dec 31, 2019 | 47.00 Mn |
| Sep 30, 2019 | 50.70 Mn |
| Jun 30, 2019 | 55.40 Mn |
| Mar 31, 2019 | 58.30 Mn |